BTAI Market Cap History
Below is a table of the BTAI market cap history going back to 3/8/2018:

Date BTAI Market Cap

Also see: BTAI Shares Outstanding History
and BTAI YTD Return
BTAI Historical Market Cap:
+54.36% CAGR
BTAI Historical Market Cap: +54.36% CAGR

Mouse over chart for data details
3/8/2018 ...8/5/2021
BioXcel Therapeutics is a clinical stage biopharmaceutical company utilizing artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology. Co.'s two key clinical development programs are BXCL501, an investigational, proprietary, orally dissolving, sublingual thin film formulation of the adrenergic receptor agonist dexmedetomidine for the treatment of agitation resulting from neuropsychiatric disorders, and BXCL701, an investigational orally administered systemic innate immune activator for the treatment of a rare form of prostate cancer and advanced solid tumors that are refractory or treatment naïve to checkpoint inhibitors. We show 14 historical shares outstanding datapoints in our BTAI shares outstanding history coverage, used to compute BTAI market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BTAI market cap history over the course of time is important for investors interested in comparing BTAI's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BTAI versus a peer is one thing; comparing BTAI market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BTAI can fluctuate over the course of history. With this page we aim to empower investors researching BTAI by allowing them to research the BTAI market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree BTAI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
BioXcel Therapeutics (BTAI) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

BTCY Market Cap History
BUG Market Cap History
BUR Market Cap History
BVS Market Cap History
BXRX Market Cap History
CABA Market Cap History
CADL Market Cap History
CAH Market Cap History
CALA Market Cap History
CAPR Market Cap History
More Healthcare companies »


BTAI Market Cap History | | Copyright © 2017 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.